Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature Medicine 11, 77 - 84 (2004)
Published online: 26 December 2004 | doi:10.1038/nm1161
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
Angela Nebbioso1, Nicole Clarke2, Emilie Voltz2, Emmanuelle Germain2, Concetta Ambrosino1, Paola Bontempo1, Rosana Alvarez3, Ettore M Schiavone4, Felicetto Ferrara4, Francesco Bresciani1, Alessandro Weisz1, Angel R de Lera3, Hinrich Gronemeyer2 & Lucia Altucci1
Abstract
Chromatin is a dynamic macromolecular structure epigenetically modified to regulate specific gene expression. Altered chromatin function can lead to aberrant expression of growth regulators and may, ultimately, cause cancer. That many human diseases have epigenetic etiology has stimulated the development of 'epigenetic' therapies. Inhibitors of histone deacetylases (HDACIs) induce proliferation arrest, maturation and apoptosis of cancer cells, but not normal cells, in vitro and in vivo, and are currently being tested in clinical trials1, 2, 3, 4, 5. We investigated the mechanism(s) underlying this tumor selectivity. We report that HDACIs induce, in addition to p21, expression of TRAIL (Apo2L, TNFSF10) by directly activating the TNFSF10 promoter, thereby triggering tumor-selective death signaling in acute myeloid leukemia (AML) cells and the blasts of individuals with AML. RNA interference revealed that the induction of p21, TRAIL and differentiation are separable activities of HDACIs. HDACIs induced proliferation arrest, TRAIL-mediated apoptosis and suppression of AML blast clonogenicity irrespective of French-American-British (FAB) classification status, karyotype and immunophenotype. No apoptosis was seen in normal CD34+ progenitor cells. Our results identify TRAIL as a mediator of the anticancer action of HDACIs.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathwayNature Medicine Letter (01 Jan 2005)
Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAILThe EMBO Journal Article (04 Aug 2004)
Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAILNature Medicine Article (01 Jun 2001)
See all 19 matches for Research